Tag: NCT04145531

Home / NCT04145531

Categories

FDA has approved asparaginase erwinia chrysanthemi (recombinant) for leukaemia and lymphoma

August 2021: The Food and Drug Administration has approved asparaginase erwinia chrysanthemi (recombinant)-rywn) (Rylaze, Jazz Pharmaceuticals, Inc.) as part of a multi-agent chemotherapeutic regimen ...
nct04145531

Scan the code